Mati Therapeutics Inc. — Form D/A

Mati Therapeutics Inc. of AUSTIN, TX, a company, filed a Form D amendment with the SEC on 2026-07-02. The offering totals $4.9M, of which $2.6M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (29)

Showing 25 of 29 people.

NameRoleLocation
Robert ButchofskyRelated PersonAustin, TX
Dave FellowsRelated PersonAustin, TX
Ken JonesRelated PersonAustin, TX
Linda LupiniRelated PersonAustin, TX
Jim MazzoRelated PersonAustin, TX
Peter McDonnellRelated PersonAustin, TX
Christopher MullerRelated PersonAustin, TX
Cameron NelsonRelated PersonAustin, TX
Joseph Tortorice IIIRelated PersonAustin, TX
Deepank UtkhedeDirectorAustin, TX
Robert ButchofskyDirectorAustin, TX
Robert ButchofskyExecutive OfficerAustin, TX
Christopher MullerDirectorAustin, TX
Christopher MullerExecutive OfficerAustin, TX
Cameron NelsonExecutive OfficerAustin, TX
Joseph Tortorice IIIDirectorAustin, TX
Robert Lee Butchofsky IIDirectorAustin, TX
Robert Lee Butchofsky IIExecutive OfficerAustin, TX
Cameron Lee NelsonExecutive OfficerVancouver, A1
Christopher Lee MullerDirectorFoothill Ranch, CA
Christopher Lee MullerExecutive OfficerFoothill Ranch, CA
Deepank Lee UtkhedeDirectorSurrey, A1
Deepank Lee UtkhedeExecutive OfficerSurrey, A1
Deepank Lee UtkedeDirectorAustin, TX
Deepank Lee UtkedeExecutive OfficerAustin, TX

Other filings by this issuer (6)

FiledFormOfferingSold
2025-10-08D$10.5M$9.9M
2025-09-23D$2.2M$2.2M
2019-05-24D$1.5M$165K
2018-10-16D$1.2M$50K
2014-10-10D$13.8M$150K
2013-04-15D$10.0M$1.3M

More